BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30807935)

  • 1. Synthesis of sulfonamide, amide and amine hybrid pharmacophore, an entry of new class of carbonic anhydrase II inhibitors and evaluation of chemo-informatics and binding analysis.
    Ahmed A; Channar PA; Saeed A; Kalesse M; Kazi MA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
    Bioorg Chem; 2019 May; 86():624-630. PubMed ID: 30807935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel aminosaccharide-based sulfonamide derivatives as potential carbonic anhydrase II inhibitors.
    Wang X; Feng YL; Zhao XY; An R; Cao C; Guo MB; Zhang R; Wang YX; Hou Z; Guo C
    Bioorg Med Chem Lett; 2021 Dec; 53():128420. PubMed ID: 34728369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the α-carbonic anhydrase from Vibrio cholerae with amides and sulfonamides incorporating imidazole moieties.
    De Vita D; Angeli A; Pandolfi F; Bortolami M; Costi R; Di Santo R; Suffredini E; Ceruso M; Del Prete S; Capasso C; Scipione L; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):798-804. PubMed ID: 28569564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and carbonic anhydrase inhibitory activities of new thienyl-substituted pyrazoline benzenesulfonamides.
    Mete E; Comez B; Inci Gul H; Gulcin I; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):1-5. PubMed ID: 27435177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of N-heteroarylsubstituted triazolosulfonamides as carbonic anhydrase inhibitors.
    Balci A; Arslan M; Nixha AR; Bilen C; Ergun A; Gençer N
    J Enzyme Inhib Med Chem; 2015 Jun; 30(3):377-82. PubMed ID: 25068730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A class of sulfonamides as carbonic anhydrase I and II inhibitors.
    Gokcen T; Gulcin I; Ozturk T; Goren AC
    J Enzyme Inhib Med Chem; 2016; 31(sup2):180-188. PubMed ID: 27353698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and carbonic anhydrase I, II, VII, and IX inhibition studies with a series of benzo[d]thiazole-5- and 6-sulfonamides.
    Abdoli M; Angeli A; Bozdag M; Carta F; Kakanejadifard A; Saeidian H; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1071-1078. PubMed ID: 28753093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and characterization of novel dioxoacridine sulfonamide derivatives as new carbonic anhydrase inhibitors.
    Kaya M; Basar E; Cakir E; Tunca E; Bülbül M
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):509-14. PubMed ID: 21846203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of different thio-scaffolds bearing sulfonamide with subnanomolar carbonic anhydrase II and IX inhibitory properties and X-ray investigations for their inhibitory mechanism.
    Angeli A; Tanini D; Capperucci A; Malevolti G; Turco F; Ferraroni M; Supuran CT
    Bioorg Chem; 2018 Dec; 81():642-648. PubMed ID: 30253337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies.
    Milite C; Amendola G; Nocentini A; Bua S; Cipriano A; Barresi E; Feoli A; Novellino E; Da Settimo F; Supuran CT; Castellano S; Cosconati S; Taliani S
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1697-1710. PubMed ID: 31537132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of N-(5-methyl-isoxazol-3-yl/1,3,4-thiadiazol-2-yl)-4-(3-substitutedphenylureido) benzenesulfonamides as human carbonic anhydrase isoenzymes I, II, VII and XII inhibitors.
    Mishra CB; Kumari S; Angeli A; Monti SM; Buonanno M; Prakash A; Tiwari M; Supuran CT
    J Enzyme Inhib Med Chem; 2016; 31(sup2):174-179. PubMed ID: 27314170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties.
    Altug C; Güneş H; Nocentini A; Monti SM; Buonanno M; Supuran CT
    Bioorg Med Chem; 2017 Feb; 25(4):1456-1464. PubMed ID: 28111158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the 'bipolar' nature of the carbonic anhydrase active site: aromatic sulfonamides containing 1,3-oxazol-5-yl moiety as picomolar inhibitors of cytosolic CA I and CA II isoforms.
    Krasavin M; Korsakov M; Dorogov M; Tuccinardi T; Dedeoglu N; Supuran CT
    Eur J Med Chem; 2015 Aug; 101():334-47. PubMed ID: 26160114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential inhibitors of human carbonic anhydrase isozymes I and II: Design, synthesis and docking studies of new 1,3,4-thiadiazole derivatives.
    Altıntop MD; Sever B; Özdemir A; Kucukoglu K; Onem H; Nadaroglu H; Kaplancıklı ZA
    Bioorg Med Chem; 2017 Jul; 25(13):3547-3554. PubMed ID: 28511907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides.
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5867-5870. PubMed ID: 27884694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors.
    Kumar R; Vats L; Bua S; Supuran CT; Sharma PK
    Eur J Med Chem; 2018 Jul; 155():545-551. PubMed ID: 29909339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of novel 5-amino-1,3,4-thiadiazole-2-sulfonamide containing acridine sulfonamide/carboxamide compounds and investigation of their inhibition effects on human carbonic anhydrase I, II, IV and VII.
    Aday B; Ulus R; Tanç M; Kaya M; Supuran CT
    Bioorg Chem; 2018 Apr; 77():101-105. PubMed ID: 29353727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors.
    Yaseen R; Ekinci D; Senturk M; Hameed AD; Ovais S; Rathore P; Samim M; Javed K; Supuran CT
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1337-41. PubMed ID: 26804228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole-benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein.
    Entezari Heravi Y; Sereshti H; Saboury AA; Ghasemi J; Amirmostofian M; Supuran CT
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):688-700. PubMed ID: 28317396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.